A-Fem Medical has filed a patent application to the US Patent Office for its RapidSense technology. The technology provides information for a range of medical tests, including a home pregnancy test the company is developing.
A-Fem files patent application for RapidSense: - Clone-one - Clone
Listen to this article
A-Fem Medical has filed a patent application to the US Patent Office for its RapidSense technology. The technology provides information for a range of medical tests, including a home pregnancy test the company is developing.
Stay ahead of every shift in generics and biosimilars.
More from Generics Bulletin
• By
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
• By
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
• By
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
• By
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.